Deaths in Colorado Attributed to Kratom
- PMID: 30601742
- PMCID: PMC6688840
- DOI: 10.1056/NEJMc1811055
Deaths in Colorado Attributed to Kratom
References
-
- Gottlieb S Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse: additional adverse events associated with kratom use identified. Silver Spring, MD: Food and Drug Administration, 2018.
-
- Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology 2018;134(Pt A):108–20. - PubMed
-
- Warner ML, Kaufman NC, Grundmann O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. Int J Legal Med 2016;130:127–38. - PubMed
-
- FDA warns companies selling illegal, unapproved kratom products marketed for opioid cessation, pain treatment, and other medical uses. Press release of the Food and Drug Administration, May 22, 2018. (https://www.fda.gov/newsevents/news-room/pressannouncements/ucm608447.htm).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources